-
1
-
-
24944507764
-
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer
-
Jones S.E., Erban J., Overmoyer B., et al. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 2005, 23:5542-5551.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5542-5551
-
-
Jones, S.E.1
Erban, J.2
Overmoyer, B.3
-
2
-
-
43249115659
-
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to Trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B Protocol 9840
-
Seidman A.D., Berry D., Cirrincione C., et al. Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to Trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B Protocol 9840. J Clin Oncol 2008, 26:1642-1649.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1642-1649
-
-
Seidman, A.D.1
Berry, D.2
Cirrincione, C.3
-
3
-
-
0035890811
-
Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer
-
Perez E., Vogel C., Irwin D., et al. Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol 2001, 19:4216-4223.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4216-4223
-
-
Perez, E.1
Vogel, C.2
Irwin, D.3
-
4
-
-
4444264966
-
Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patients
-
Baltali E., Altundag K., Ozisik Y., et al. Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patients. Tohoku J Exp Med 2004, 203:205-210.
-
(2004)
Tohoku J Exp Med
, vol.203
, pp. 205-210
-
-
Baltali, E.1
Altundag, K.2
Ozisik, Y.3
-
5
-
-
0003302513
-
A promising second line treatment with weekly paclitaxel in anthracycline recurrent, advanced breast cancer patients
-
[abstract 515]
-
Mickiewicz E. A promising second line treatment with weekly paclitaxel in anthracycline recurrent, advanced breast cancer patients. Proc Am Soc Clin Oncol 1999, 18:135a. [abstract 515].
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Mickiewicz, E.1
-
6
-
-
0031757277
-
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of advanced breast cancer
-
Seidmann A.D., Hudis C.A., Albanell J., et al. Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of advanced breast cancer. J Clin Oncol 1998, 16:3353-3361.
-
(1998)
J Clin Oncol
, vol.16
, pp. 3353-3361
-
-
Seidmann, A.D.1
Hudis, C.A.2
Albanell, J.3
-
7
-
-
0000901072
-
Phase II study of weekly paclitaxel treatment in recurrent breast cancer after high-dose chemotherapy
-
[abstract 245]
-
Sola C. Phase II study of weekly paclitaxel treatment in recurrent breast cancer after high-dose chemotherapy. Proc Am Soc Clin Oncol 1999, 18:65a. [abstract 245].
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Sola, C.1
-
8
-
-
0001521006
-
Phase II study to evaluate the efficacy of weekly paclitaxel in patients with advanced breast cancer who have failed prior anthracyclines±taxane therapy
-
[abstract 530]
-
Waintraub S.E., Cantwell S., DeVries J. Phase II study to evaluate the efficacy of weekly paclitaxel in patients with advanced breast cancer who have failed prior anthracyclines±taxane therapy. Proc Am Soc Clin Oncol 1999, 18:138a. [abstract 530].
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Waintraub, S.E.1
Cantwell, S.2
DeVries, J.3
-
9
-
-
2942525789
-
Taxanes in elderly breast cancer patients
-
Wildiers H., Paridaens R. Taxanes in elderly breast cancer patients. Cancer Treat Rev 2004, 30:333-342.
-
(2004)
Cancer Treat Rev
, vol.30
, pp. 333-342
-
-
Wildiers, H.1
Paridaens, R.2
-
10
-
-
0035985491
-
Weekly paclitaxel in women age 65 and above with metastatic breast cancer
-
Perez E.A., Vogel L., Irwin D., et al. Weekly paclitaxel in women age 65 and above with metastatic breast cancer. Breast Cancer Res Treat 2002, 73:85-88.
-
(2002)
Breast Cancer Res Treat
, vol.73
, pp. 85-88
-
-
Perez, E.A.1
Vogel, L.2
Irwin, D.3
-
11
-
-
9144259968
-
Weekly paclitxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicenter phase II trial
-
Ten Tije A.J., Smorenburg C.H., Seynaeve C., et al. Weekly paclitxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicenter phase II trial. Eur J Cancer 2004, 40:352-357.
-
(2004)
Eur J Cancer
, vol.40
, pp. 352-357
-
-
Ten Tije, A.J.1
Smorenburg, C.H.2
Seynaeve, C.3
-
12
-
-
4644357450
-
A multicentre, randomised phase II study of weekly or three-weekly docetaxel in patients with metastatic breast cancer
-
Tabernero J., Climent A., Lluch A., et al. A multicentre, randomised phase II study of weekly or three-weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 2004, 9:1358-1365.
-
(2004)
Ann Oncol
, vol.9
, pp. 1358-1365
-
-
Tabernero, J.1
Climent, A.2
Lluch, A.3
-
13
-
-
0034061842
-
Docetaxel administered on a weekly basis for metastatic breast cancer
-
Burstein H.J., Manola J., Younger J., et al. Docetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol 2000, 18:1212-1219.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1212-1219
-
-
Burstein, H.J.1
Manola, J.2
Younger, J.3
-
14
-
-
0001655121
-
Dose dense weekly docetaxel in metastatic breast cancer
-
[abstract 527]
-
Löffler T., Dröge C., Hausamen T.U. Dose dense weekly docetaxel in metastatic breast cancer. Breast Cancer Res Treat 1999, 57:125. [abstract 527].
-
(1999)
Breast Cancer Res Treat
, vol.57
, pp. 125
-
-
Löffler, T.1
Dröge, C.2
Hausamen, T.U.3
-
15
-
-
33748476262
-
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
-
Ford H.E., Yap Y.S., Miles D., et al. A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer Chemother Pharmacol 2006, 58:809-815.
-
(2006)
Cancer Chemother Pharmacol
, vol.58
, pp. 809-815
-
-
Ford, H.E.1
Yap, Y.S.2
Miles, D.3
-
16
-
-
0036302586
-
Phase II study of weekly docetaxel in patients with metastatic breast cancer
-
Aihara T., Kim Y., Takatsuka Y. Phase II study of weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 2002, 13:286-292.
-
(2002)
Ann Oncol
, vol.13
, pp. 286-292
-
-
Aihara, T.1
Kim, Y.2
Takatsuka, Y.3
-
17
-
-
0035184370
-
Weekly docetaxel in patients with metastatic breast cancer
-
Stemmler H.J., Gutschow K., Sommer H., et al. Weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 2001, 12:1393-1398.
-
(2001)
Ann Oncol
, vol.12
, pp. 1393-1398
-
-
Stemmler, H.J.1
Gutschow, K.2
Sommer, H.3
-
18
-
-
35348835960
-
Improvement of safety profile of docetaxel by weekly administration in patients with metastatic breast cancer
-
Warm M., Nawroth F., Ohlinger R., et al. Improvement of safety profile of docetaxel by weekly administration in patients with metastatic breast cancer. Onkologie 2007, 30:436-441.
-
(2007)
Onkologie
, vol.30
, pp. 436-441
-
-
Warm, M.1
Nawroth, F.2
Ohlinger, R.3
-
19
-
-
0001910252
-
Weekly docetaxel in patients with advanced malignancies. Toxicity profile and activities results
-
[abstract 453]
-
Climent M.A., Ruiz A., Llombart-Cussac A., et al. Weekly docetaxel in patients with advanced malignancies. Toxicity profile and activities results. Proc Am Soc Clin Oncol 1999, 18:119a. [abstract 453].
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Climent, M.A.1
Ruiz, A.2
Llombart-Cussac, A.3
-
20
-
-
0035424043
-
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network Phase II Trial
-
Hainsworth J.D., Burris H., Yardley D., et al. Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network Phase II Trial. J Clin Oncol 2001, 19:3500-3505.
-
(2001)
J Clin Oncol
, vol.19
, pp. 3500-3505
-
-
Hainsworth, J.D.1
Burris, H.2
Yardley, D.3
-
21
-
-
1942452823
-
Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study
-
D'hondt R., Paridaens R., Wildiers H., et al. Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study. Anticancer Drugs 2004, 4:341-346.
-
(2004)
Anticancer Drugs
, vol.4
, pp. 341-346
-
-
D'hondt, R.1
Paridaens, R.2
Wildiers, H.3
-
22
-
-
0000259332
-
-
X Ellis RE: the distribution of active bone marrow in the adult. Phys Med Biol.
-
X Ellis RE: the distribution of active bone marrow in the adult. Phys Med Biol 1961;255-8.
-
(1961)
, pp. 255-8
-
-
-
23
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
February
-
Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92(February(3)):205-216.
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
24
-
-
50549174560
-
The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
-
Gehan E.A. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chron Dis 1961, 13(4):346-353.
-
(1961)
J Chron Dis
, vol.13
, Issue.4
, pp. 346-353
-
-
Gehan, E.A.1
-
25
-
-
42249083269
-
Weekly paclitaxel in the adjuvant treatment of breast cancer
-
Sparano J.A., Wang M., Martino S., et al. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 2008, 358(16):1663-1671.
-
(2008)
N Engl J Med
, vol.358
, Issue.16
, pp. 1663-1671
-
-
Sparano, J.A.1
Wang, M.2
Martino, S.3
-
26
-
-
62549131714
-
The cancer survival gap between elderly and middle-aged patients in Europe is widening
-
Quaglia A., Tavilla A., Shack L., et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009, 6:1006-1016.
-
(2009)
Eur J Cancer
, vol.6
, pp. 1006-1016
-
-
Quaglia, A.1
Tavilla, A.2
Shack, L.3
|